Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study-Reference-Cited by-同舟云学术

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study

Published:2012-09 Issue:9 Volume:13 Page:927-935
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Harshman Lauren C,Xie Wanling,Bjarnason Georg A,Knox Jennifer J,MacKenzie Mary,Wood Lori,Srinivas Sandy,Vaishampayan Ulka N,Tan Min-Han,Rha Sun-Young,Donskov Frede,Agarwal Neeraj,Kollmannsberger Christian,North Scott,Rini Brian I,Heng Daniel YC,Choueiri Toni K

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival;Escudier;J Clin Oncol,2010

3. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma;Motzer;J Clin Oncol,2002

4. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2009

5. Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206;Rini;J Clin Oncol,2010

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma;BMC Cancer;2024-08-17

2. A novel cancer-associated fibroblasts risk score model predict survival and immunotherapy in lung adenocarcinoma;Molecular Genetics and Genomics;2024-07-17

3. Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm;Medical Oncology;2023-07-14

4. Collecting duct carcinoma: Epidemiology, clinical characteristics and survival;Urologic Oncology: Seminars and Original Investigations;2023-02

5. Contemporary conditional cancer‐specific survival rates in surgically treated adrenocortical carcinoma patients: A stage‐specific analysis;Journal of Surgical Oncology;2022-11-26